Dx2010: Markers to Market -- hearing from attendees: Richard Strafehl, Safeguard Biosystems

Richard Strafehl, CEO, Safeguard Biosystems.
The Dx2010 Markers to Market workshop (June 22, 2010) brought together leading international researchers, regulatory representatives and entrepreneurs from the diagnostics sector to examine regulatory hurdles and commercialization challenges on the path from biomarker discovery to market for molecular diagnostics and prognostics.
Dx2010 Markers to Market was co-hosted by the Ontario Genomics Institute (OGI) with the MaRS Discovery District.

Category:

Science & Technology

Tags:

• OGI
• genomics
• Dx2010
• markers to market
• molecular diagnostics
• regulatory
• regulation
• biomarker
• commercialization
• diagnostics
• life sciences
• Ontario Genomics Institute
• MaRS Discovery District
• MaRS
• Safeguard
• Safeguard Biosystems
• Richard Strafehl